240 related articles for article (PubMed ID: 25480875)
1. Patterns of practice of regional nodal irradiation in breast cancer: results of the European Organization for Research and Treatment of Cancer (EORTC) NOdal Radiotherapy (NORA) survey.
Belkacemi Y; Kaidar-Person O; Poortmans P; Ozsahin M; Valli MC; Russell N; Kunkler I; Hermans J; Kuten A; van Tienhoven G; Westenberg H;
Ann Oncol; 2015 Mar; 26(3):529-35. PubMed ID: 25480875
[TBL] [Abstract][Full Text] [Related]
2. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
[TBL] [Abstract][Full Text] [Related]
4. Practice Patterns of Radiation Field Design for Sentinel Lymph Node-Positive Early-Stage Breast Cancer.
Azghadi S; Daly M; Mayadev J
Clin Breast Cancer; 2016 Oct; 16(5):410-417.e3. PubMed ID: 27266803
[TBL] [Abstract][Full Text] [Related]
5. Regional radiotherapy after primary systemic treatment for cN+ breast cancer patients.
Boersma LJ; Mjaaland I; van Duijnhoven F
Breast; 2023 Apr; 68():181-188. PubMed ID: 36805769
[TBL] [Abstract][Full Text] [Related]
6. Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients?
Sávolt A; Polgár C; Musonda P; Mátrai Z; Rényi-Vámos F; Tóth L; Kásler M; Péley G
Clin Breast Cancer; 2013 Oct; 13(5):364-70. PubMed ID: 23773380
[TBL] [Abstract][Full Text] [Related]
7. Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society.
Imoto S; Yamauchi C; Komoike Y; Tsugawa K; Yotsumoto D; Wada N; Ueno T; Oba MS; Shien T; Sugae S; Tsuda H; Yoneyama K
Breast Cancer; 2017 May; 24(3):427-432. PubMed ID: 27553957
[TBL] [Abstract][Full Text] [Related]
8. Axillary lymph node treatment in breast cancer: an update.
Williams PA; Suggs J; Mangana SH
J Miss State Med Assoc; 2014 May; 55(5):145-7. PubMed ID: 25112128
[TBL] [Abstract][Full Text] [Related]
9. Axillary nodal irradiation practice in the sentinel lymph node biopsy era: Comparison of the contemporary available 3D and IMRT techniques.
Belkacemi Y; Loganadane G; Ghith S; Li X; Majdoul S; Grellier N; Jmour O; Bret CL; Hervé ML; Hadhri A; To NH; Fayolle-Campana M; Colson-Durand L
Br J Radiol; 2020 Jun; 93(1110):20190351. PubMed ID: 32233939
[TBL] [Abstract][Full Text] [Related]
10. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
Henke G; Knauer M; Ribi K; Hayoz S; Gérard MA; Ruhstaller T; Zwahlen DR; Muenst S; Ackerknecht M; Hawle H; Fitzal F; Gnant M; Mátrai Z; Ballardini B; Gyr A; Kurzeder C; Weber WP
Trials; 2018 Dec; 19(1):667. PubMed ID: 30514362
[TBL] [Abstract][Full Text] [Related]
11. Axillary Management in Breast Cancer Patients Undergoing Upfront Surgery: Results from a Nationwide Survey on Behalf of the Clinical Oncology Breast Cancer Group (COBCG) and the Breast Cancer Study Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
De Rose F; Colciago RR; Lucidi S; La Rocca E; Prisco A; Bonzano E; Meduri B; De Santis MC; Dicuonzo S; Pasinetti N; Palumbo I; Meattini I; Franco P
Curr Oncol; 2023 Aug; 30(8):7489-7498. PubMed ID: 37623023
[TBL] [Abstract][Full Text] [Related]
12. Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
Gingras I; Holmes E; De Azambuja E; Nguyen DH; Izquierdo M; Anne Zujewski J; Inbar M; Naume B; Tomasello G; Gralow JR; Wolff AC; Harris L; Gnant M; Moreno-Aspitia A; Piccart MJ; Azim HA
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376188
[TBL] [Abstract][Full Text] [Related]
13. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy of the regional lymph nodes: shooting at the sheriff?
Kunkler IH
Breast; 2009 Oct; 18 Suppl 3():S112-20. PubMed ID: 19914529
[TBL] [Abstract][Full Text] [Related]
15. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Dar AR; Venkatesan VM; Stitt L; Radwan JS
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):551-9. PubMed ID: 9231679
[TBL] [Abstract][Full Text] [Related]
16. Lymph nodal radiotherapy in breast cancer: what are the unresolved issues?
Fozza A; Giaj-Levra N; De Rose F; Ippolito E; Silipigni S; Meduri B; Fiorentino A; Gregucci F; Marino L; Di Grazia A; Cucciarelli F; Borghesi S; De Santis MC; Ciabattoni A
Expert Rev Anticancer Ther; 2021 Aug; 21(8):827-840. PubMed ID: 33852379
[No Abstract] [Full Text] [Related]
17. Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers: A Prospective Validation Study of 793 Patients.
Morrow M; Van Zee KJ; Patil S; Petruolo O; Mamtani A; Barrio AV; Capko D; El-Tamer M; Gemignani ML; Heerdt AS; Kirstein L; Pilewskie M; Plitas G; Sacchini VS; Sclafani LM; Ho A; Cody HS
Ann Surg; 2017 Sep; 266(3):457-462. PubMed ID: 28650355
[TBL] [Abstract][Full Text] [Related]
18. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
[TBL] [Abstract][Full Text] [Related]
19. Axillary Management in Breast Cancer Patients: A Comprehensive Review of the Key Trials.
Yan M; Abdi MA; Falkson C
Clin Breast Cancer; 2018 Dec; 18(6):e1251-e1259. PubMed ID: 30262257
[TBL] [Abstract][Full Text] [Related]
20. Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients With Pathologic Negative Nodes After Neoadjuvant Chemotherapy.
Schlafstein A; Liu Y; Goyal S; Kahn S; Godette K; Lin J; Torres MA; Royce TJ; Patel SA
Clin Breast Cancer; 2022 Feb; 22(2):127-135. PubMed ID: 34229943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]